RecruitingNCT05527080

Development of Motility and Cognition in Infants


Sponsor

Helsinki University Central Hospital

Enrollment

250 participants

Start Date

Oct 1, 2021

Study Type

OBSERVATIONAL

Conditions

Summary

PILKE study uses wearables for assessing motor development in infants in order to define functional growth trajectories in the normal infants and infants at risk of neurological compromise. In addition, PILKE studies correlation of early motor development to later neurocognitive development.


Eligibility

Min Age: 5 MonthsMax Age: 26 Months

Inclusion Criteria2

  • age at enrollment 5-8mos
  • typically developing

Exclusion Criteria3

  • all neurologically significant medical histories during pregnancy, at birth or postnatally
  • suspicion of developmental delay
  • suspicion or diagnosis of syndromes with neuromotor symptoms

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERphysiotherapy

Some infants will receive physiotherapy as a part of their clinically indicated care.

DEVICEbrace

Some infants in the hip dysplasia group will receive brace and/or cast as a part of their clinically indicated care


Locations(1)

BABA, Clinical Trial Unit, New Children's Hospital

Helsinki, Finland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05527080


Related Trials